血液製品市場：依產品類型、應用、技術、患者屬性、最終用戶和地區分類

Blood Products Market, By Product Category, By Application, By Technology, By Patient Demographics, By End User, By Geography

出版日期: 2025年06月09日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年血液製品市場規模估計為 382 億美元，預計到 2032 年將達到 526.9 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 4.7%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	382億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	4.70%	2032年價值預測	526.9億美元

近年來，受慢性病發病率上升、輸血需求成長以及血液處理和儲存技術進步的推動，全球血液製品市場經歷了顯著成長。血液製品，包括全血、紅血球、血小板、血漿及其他衍生物，在各種醫療程序和療法中發揮至關重要的作用。市場涵蓋的產品種類繁多，例如白蛋白、免疫球蛋白、凝血因子和其他血漿衍生產品。隨著全球醫療保健產業的不斷發展以及對救命血液製品需求的不斷成長，預計未來幾年血液製品市場將大幅成長。

市場動態：

全球血液製品市場受多種關鍵因素影響，這些因素推動其成長、限制其擴張，並為相關人員提供機會。市場促進因素之一是癌症、心血管疾病和血液疾病等慢性疾病的日益流行，這些疾病通常需要輸血和其他血液相關治療。此外，全球老年人口的成長和外科手術的增加也促進了血液製品需求的成長。然而，該市場也存在一些限制因素，例如與血液採集、處理和儲存相關的高成本以及輸血感染風險。此外，嚴格的監管要求和血液製品的保存期限有限也對市場成長構成了挑戰。儘管存在這些市場限制因素，但血液製品市場仍提供了巨大的成長機會。

本研究的主要特點

本報告對全球血液製品市場進行了詳細分析，並提供了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率(CAGR)，假設基準年為 2024 年。
它還強調了各個領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
全球血液製品市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球血液製品市場報告迎合了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過分析全球血液製品市場所使用的各種策略矩陣來促進決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 38.20 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	4.70%	2032 Value Projection:	USD 52.69 Bn

The global blood products market has witnessed significant growth in recent years, driven by the increasing prevalence of chronic diseases, the rising demand for blood transfusions, and advancements in blood processing and storage technologies. Blood products, including whole blood, red blood cells, platelets, plasma, and other derivatives, play a crucial role in various medical procedures and treatments. The market encompasses a wide range of products such as albumin, immunoglobulins, coagulation factors, and other plasma-derived products. As the global healthcare industry continues to evolve and the demand for life-saving blood products rises, the blood products market is poised for substantial growth in the coming years.

Market Dynamics:

The global blood products market is influenced by several key factors that drive its growth, restrain its expansion, and present opportunities for stakeholders. One of the primary drivers of the market is the increasing prevalence of chronic diseases, such as cancer, cardiovascular disorders, and hematological conditions, which often require blood transfusions and other blood-related treatments. Additionally, the growing geriatric population worldwide, coupled with the rising incidence of surgical procedures, contributes to the heightened demand for blood products. However, the market also faces certain restraints, including the high costs associated with blood collection, processing, and storage, as well as the risk of transfusion-transmitted infections. Moreover, stringent regulatory requirements and the limited shelf life of blood products pose challenges to market growth. Despite these restraints, the blood products market presents significant opportunities for growth, such as the development of advanced blood processing technologies, the increasing adoption of automation in blood banks, and the expansion of plasma-derived therapies. Furthermore, the rising demand for blood products in emerging economies, driven by improving healthcare infrastructure and increasing healthcare expenditure, offers substantial growth prospects for market players.

Key Features of the Study:

This report provides in-depth analysis of the global blood products market, and provides market size (USD Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global blood products market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Grifols, CSL Behring, Fresenius Kabi, Octapharma, Takeda Pharmaceutical Company, Sanofi, Kedrion Biopharma, Biotest AG, Mitsubishi Tanabe Pharma Corporation, HemaCare, BloodCenter of Wisconsin, Terumo BCT, Prothera Biosciences, American Red Cross, and Vitalant
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global blood products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood products market

Market Segmentation

Product Category Insights (Revenue, USD Bn, 2020 - 2032)
- Whole Blood
- Blood Components
- Red Blood Cells (RBCs)
- Platelets
- Plasma
- White Blood Cells (WBCs)
- Cryoprecipitate
- Plasma-derived Products
- Immunoglobulins
- Albumin
- Coagulation Factors
- Hyperimmune Globulins
- Others
Application Insights (Revenue, USD Bn, 2020 - 2032)
- Hematology
- Immunology
- Neurology
- Oncology
- Hematology
- Others
Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Manual Blood Collection and Processing
- Automated Blood Collection Systems
- Blood Fractionation and Plasma Separation
- Pathogen Reduction Technologies
- Precision Blood Typing and Grouping Systems
- Others
Patient Demographics Insights (Revenue, USD Bn, 2020 - 2032)
- Pediatric Patients
- Adult Patients
- Geriatric Patients
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Blood Banks
- Ambulatory Surgical Centers
- Transfusion Centers
- Diagnostic Laboratories
- Research Institutions
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Grifols
- CSL Behring
- Fresenius Kabi
- Octapharma
- Takeda Pharmaceutical Company
- Sanofi
- Kedrion Biopharma
- Biotest AG
- Mitsubishi Tanabe Pharma Corporation
- HemaCare
- BloodCenter of Wisconsin
- Terumo BCT
- Prothera Biosciences
- American Red Cross
- Vitalant

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Blood Products Market, By Product Category
- Global Blood Products Market, By Application
- Global Blood Products Market, By Technology
- Global Blood Products Market, By Patient Demographics
- Global Blood Products Market, By End User
- Global Blood Products Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Blood Products Market, By Product Category, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Whole Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Blood Components
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Red Blood Cells (RBCs)
  - Platelets
  - Plasma
  - White Blood Cells (WBCs)
  - Cryoprecipitate
Plasma-derived Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Immunoglobulins
  - Albumin
  - Coagulation Factors
  - Hyperimmune Globulins
  - Others

5. Global Blood Products Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hematology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Immunology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hematology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Blood Products Market, By Technology, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Manual Blood Collection and Processing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Automated Blood Collection Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Blood Fractionation and Plasma Separation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pathogen Reduction Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Precision Blood Typing and Grouping Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Blood Products Market, By Patient Demographics, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pediatric Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Adult Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Geriatric Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Blood Products Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Blood Banks
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Transfusion Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Blood Products Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Category, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Category, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Category, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Category, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Category, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Category, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Grifols
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
CSL Behring
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fresenius Kabi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Octapharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takeda Pharmaceutical Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Kedrion Biopharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Biotest AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mitsubishi Tanabe Pharma Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
HemaCare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BloodCenter of Wisconsin
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Terumo BCT
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Prothera Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
American Red Cross
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Vitalant
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies